City Center (Community Out Reach Programme)
Puran Barzar, Ludhiana

 Volume 4 No. 1  

April - 2004

City Center


The city center is treating all types of diseases under one roof. All OPD’s including Medicine, Surgery, Gynae & Obst., Orthopedics, Eye, ENT, Chest & TB, Skin, Pediatrics, Dental, Family Planning Clinic and Well Person Clinics are running on regular basis.

The centre is open for the public from Morning till Evening for giving quality treatment. Basic diagnostic facilities like X-ray, Ultrasound Abdomen, ECG and all routine Lab Investigations are done at center.

The city center is also having a day care surgery operation theatre. Those patients who


will require admission and specialized investigations are being referred to Mohan Dai Oswal Cancer Treatment & Research Foundation and are being given 25% or more discount in needy cases.

The Sr. Doctors from the ma main hospital are visiting the center for expert advise on regular basis.




 

 Uterine Balloon Therapy


Menorrhagia i.e. excessive bleeding during periods is one of the common gynecological problems. More than 1 in 5 women around the globe suffer from menorrhagia. It is the most common indication for hysterectomy which has a primary success rate of 100% in this problem. 20% of British women after the age of 55 have undergone hysterectomy with menorrhagia as an indication in 35-64%. Regardless of the route it is performed, Hysterectomy is a major surgical procedure with associated risks of anesthesia, blood loss, injury to nearby organs, sepsis and post operative ambulation and recovery. In patients with menorrhagia who don’t have any anatomical lesion (with a normal uterus) the site of disease is primarily in the endometrium, so that removal of myometrium i.e. uterus is not required. With emergence of this concept various new surgical techniques are coming up in practice where only endometrium is being destroyed. Uterine balloon therapy relies on a concept of the combination of heating under pressure within the uterine cavity to achieve the destruction of endometrium and superficial myometrium. The distensibility of the balloon allows it to take the shape of the endometrial cavity.
The preoperative evaluation of these patients involves the work up to exclude other causes of menorrhagia. A pelvic ultrasound including a transvaginal scan is done to measure the endometrial cavity (optimum 8 cm) endometrial thickness (3-5 mm) and exclude the presence of any fibroids and endometrial polyp as a cause of menorrhagia. Routine Pap smear and endometrial curettage with histopatholgical examination of the curettings for exclusion of malignancy is mandatory. The procedure
is carried only in patients who have already completed their family and not desirous of future pregnancy.
The thermachoice balloon therapy which is the currently available balloon therapy system consists of a 16 cm long by 4.5 mm wide catheter with a latex balloon at its distal end which houses the heating element. The catheter is connected to a control unit that monitors, displays and controls preset intrauterine balloon pressure, temperature and duration of therapy. The therapy is given over a period of 8 min at a pressure of 160-180 mm of Hg and temperature of 870C. Measurement of serosal temperature and depth of thermal injury at these parameters have been studied in various in vivo and experimental studies.
 


In vivo, serosal temp from 12 different serosal locations did not exceed 39.90c with a mean of 36.10C. Histological examination revealed deep endometrial and superficial myometrial damage to all areas. The greater depth of myometrial injury occurred in fundus (3.4 mm). No thermal effect could be demonstrated in myometrium beyond 15 mm. In a large observational multicentre study, no intraoperative complications were observed.
The advantage of balloon therapy is that it requires less time, minimal anesthesia, little if any cervical dilation and no hospitalization. Considering the period of post op recovery, the total cost of treatment is much less than hysterectomy. 88% of women develop amenorrhea and at 3 years follow up high percentage (93-96%) of patients show satisfactory results. Failure in therapy may occur due to associated morbid
conditions e.g. fibroids, adenomyosis and endometriosis which go undetected. With increasing size of uterus and increase in degree of menorrahagia, lower success rates are observed.
Under the present scenario, endometrial thermal ablation therapy is well established alternative to hysterectomy in well selected group of patients. It should always be offered to all women who have completed their family wishing to have a surgical procedure for the treatment of menorrhagia in the absence of associated pelvic lesions. The facility is at present available at Mohan Dai Oswal Cancer Treatment & Research Foundation at low cost

Dr. Mrs. Veena Jain, MD, FICS, FICMCH
Chief of Obst. & Gynae and Gynaecology Oncology

Back   |   Next

| HomeAbout Hospital  |  Staff   |   Contact Us  |  News  |  Registration O.P.D. Schedule |

Copyright © 2002-2003 M.D. Oswal Cancer Treatment & Research Foundation, Ludhiana.  All rights reserved.

Website Designed & Hosted By Gravity Infosys